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Background: It has been well documented that the maturing oocyte is very vulnerable to changes in its
micro-environment, the follicular fluid (FF). Recent research has focused on different components within this FF, like
hormones, growth factors and metabolites, and how their concentrations are altered by diet and the metabolic
health of the mother. It has been proposed that fatty acids (FAs) are potential factors that influence oocyte
maturation and subsequent embryo development. However, a thorough study of the specific FF FA composition
per lipid fraction and how this may be affected by BMI is currently lacking. Therefore, we investigated the
BMI-related concentration of FAs in the phospholipid (PL), cholesteryl-ester (CHE), triglyceride (TG) and
non-esterified (NE) lipid fraction in the FF of women undergoing assisted reproductive treatment (ART).
Methods: In this descriptive cross-sectional study, the FF of normal weight (18.5 ≤ BMI < 25.0 kg/m(2), n = 10),
overweight (25.0 ≤ BMI < 30.0 kg/m(2), n = 10) and obese (BMI ≥ 30.0 kg/m(2), n = 10) women, undergoing ART,
was sampled and analyzed for 23 specific FAs in the PL, CHE, TG and NEFA fraction, using a gas chromatographic
analysis method. Differences between BMI-groups were studied by means of univariate general linear models and
post hoc Sheffé tests.
Results: Total FA concentrations in the PL and CHE fraction did not differ between BMI groups. Total TG
concentrations tended to differ and total NEFA concentrations differed significantly between BMI groups.
Interestingly, 42% and 34% of the total FAs was esterified in the PL and CHE fraction, respectively, while only 10%
were present in both the TG and NEFA fraction. Only few individual FA concentrations differed in the PL, CHE and
TG fraction between BMI groups, whereas abundant BMI-related differences were found in the NEFA fraction.
Conclusions: Our data show that differences in BMI are associated with alterations in the FA composition of the FF,
an effect most pronounced in the NEFA fraction. These BMI-related variations could possibly affect granulosa cell
viability, oocyte developmental competence and subsequent embryo quality possibly explaining differences in
oocyte quality in obese patients described by others.
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Fatty acids (FAs) are important compounds in the
micro-environment of the ovarian follicle. Besides their
role as cellular energy source, they have important bio-
logical functions in cell membrane biogenesis [1,2] and
signaling [3]. In addition, they act as precursors for
steroids and prostaglandins, which are essential for
normal reproductive function [4]. In the follicular fluid
(FF), FAs are present in an esterified form [triglycerides
(TG), cholesterol esters (CHE) and phospholipids (PL)]
or as non-esterified FAs (NEFAs), mainly bound to albu-
min [5]. Maternal diet can have a profound effect on
the FA composition of the FF, which may subsequently
affect the FA composition of the cumulus cells and
the oocyte [6-8]. Numerous animal studies, mostly in
cattle, sheep and rodents, have demonstrated the effect
of diet-induced FA changes on ovarian physiology in
general and on the quality of the oocyte more specific-
ally [6,8-10]. Dietary induced FA changes or obesogenic
diets during oocyte maturation or early embryo develop-
ment affect oocyte and embryo quality [11,12] and these
effects may even have consequences for the offspring’s
health [13,14]. However, results of these studies are not
always in agreement and difficult to compare as not only
the quantity of the FA offered, but also the physiological
status, the type of FA (ratios of omega-3, -6 or −9 FAs,
number of double bonds, carbon chain length) and the
duration of treatment may determine the final FA con-
centrations in the FF [3]. Besides dietary effects, body
condition and metabolic status may also impact on the
profile of FAs in the FF [15]. Metabolic disorders such
as obesity and type II diabetes, but also a negative energy
balance, are associated with upregulated lipolysis, lead-
ing to elevated NEFA concentrations in the serum [16],
that are reflected in the FF of the dominant follicle
[15,17] and could therefore directly affect oocyte quality
and metabolism. It has been shown that TG and NEFA
concentrations are increased in the FF of obese women
subjected to ovum pick-up [18], while such elevated
NEFA and/or TG concentrations were negatively associ-
ated with human cumulus-oocyte-complex morphology
[19] and affected both murine oocyte maturation [18]
and bovine embryo quality [20,21]. Other studies investi-
gating the influence of serum or FF FAs on fertility in
general and oocyte quality more specifically, are difficult
to compare as experimental designs, number and treat-
ment of patients included and the relation between spe-
cific FAs studied and fertility outcome parameters often
differ [19,22,23]. Additional to the heterogeneity in study
design, most research on FAs has focused on the total
fat fraction, rather than investigating FA differences in
different lipid fraction. This is important though, be-
cause the cellular response to FAs possibly depends on
the lipid fraction the FA belongs to. For this reason,knowledge on the specific FA composition of each lipid
fraction in human FF is essential. In this study, we hy-
pothesized that the FF FA composition may be altered
by the woman’s metabolic body condition (as determined
by her body mass index, BMI), being a well-documented
risk factor for fertility failure [24]. Therefore, we aimed
(1) to determine the quantity, the distribution and the
relative abundance of FAs in different lipid fractions
(PL, CHE, TG and NEFA) in the FF of the dominant fol-
licle of normal weight, overweight and obese women,
undergoing assisted reproductive treatment (ART) and
(2) to define how this FA distribution is affected by BMI
in these women. To our knowledge, this is the first time
that a detailed description of FA concentrations and
abundance in different lipid fractions in the FF of nor-
mal weight, overweight and obese women, undergoing
ART is provided. This study further discusses potential
implications of BMI-related FF FA changes on oocyte and
embryo quality.
Methods
Patients and follicular fluid sampling
This descriptive cross-sectional study was approved by
the ethical committees of the University of Antwerp (UA
A09-04) and the ZNA Middelheim Hospital (EC 3352).
Women seeking assisted reproductive services were re-
cruited (voluntary informed consent) at the Center for
Reproductive Medicine of the ZNA Middelheim Hos-
pital. Patients were treated with a long agonist protocol,
followed by ovum pick-up, in vitro fertilization (IVF) or
intra-cytoplasmic sperm injection (ICSI) and embryo
transfer on Day 3 of culture as described by Valckx et al.
[17]. Height (m) and weight (kg) of the patients were
used to calculate the body mass index (BMI) score (kg/m2).
Ten patients were randomly selected for each BMI group
out of a population of approximately 100 women from
our previous study [17]. The single criterion for this
selection was 18.5 ≤ BMI < 25.0 kg/m2 for the normal
weight group, 25.0 ≤ BMI < 30 kg/m2 for the overweight
group and BMI ≥ 30.0 kg/m2 for the obese group, accord-
ing to the standards of the World Health Organization
[25]. Male and female subfertility etiologies were docu-
mented and further patient specific data included the age
of the patient (years), IVF attempt number, ratio ICSI/IVF,
dosage of gonadotropins used (IU), maximal serum estra-
diol values (pg/ml), the number of oocytes aspirated upon
oocyte retrieval, the number of fertilized oocytes (present-
ing with 2 pronuclei, 2PN), the number of embryos pro-
duced, the number of top quality embryos, the number of
embryos transferred and the number of live births. Be-
sides, several ratios were calculated as surrogate markers
for oocyte quality: percentage of 2PN (n. 2PN /n. oocytes),
percentage of embryos (n. embryos /n. oocytes), percent-
age of top quality embryos (n. top quality embryos /n. of
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bryos developing from fertilized oocytes (n. embryos /n.
2PN and n. top quality embryos /n. 2PN, respectively). A
top quality embryo was defined as an embryo with: (i) four
or five blastomeres on Day 2, and seven or more blasto-
meres on Day 3 (ii) 20% fragmentation or less on Day 3
and (iii) no multi-nucleated blastomeres ever as described
by Van Royen et al. [26].
For each patient, the FF of the largest and first punc-
tured follicle was recovered during the oocyte retrieval
procedure by means of a transvaginal follicular aspir-
ation. Only patients with a blood free aspirate of a fol-
licle ≥ 18 mm were considered for inclusion in the study.
The FF samples were cooled immediately after aspiration
and were transported on ice within 2 h of collection. At
the laboratory, FF samples were centrifuged (1500 g,
10 min) and the supernatant was stored at −80°C until
all 30 samples were analyzed for various FAs by means
of gas chromatography.
Gas chromatographic analysis of follicular fluid
Lipids in the FF supernatant were extracted with methyl-
tert-butyl-ether as described by Matyash et al. [27]. Lipid
fractions were separated using SPE-columns [28,29].
Total plasma lipid extracts were dissolved in chloroform
(1.0 ml) and applied to an aminopropyl silica column (pas-
teur pipette containing 100 mg aminopropyl silica gel)
under gravity. Cholesteryl-esters and TGs were eluted
with chloroform (1.0 ml and 0.5 ml), combined, dried
under N2 and dissolved in 1.0 ml hexane. Non-esterified
FAs were eluted with diethyl ether/acetic acid (100:2;
1.0 ml and 0.5 ml) and PLs with 1 ml methanol/chloro-
form (6:1) followed by 0.5 ml 0.05 M sodium acetate in
methanol/chloroform (6:1). Cholesteryl-esters and TGs
were further separated on a pre-packed 100 mg aminopro-
pyl column (Varian). The CHE and TG fractions were
loaded in 1 ml hexane and the CHE fraction was eluted
with hexane (1.0 ml and 0.5 ml). Triglycerides were eluted
with hexane/chloroform/ethyl acetate (100:5:5; 1.0 ml and
0.5 ml). Fatty acids in lipid extracts were methylated using
a basic followed by an acid methylation step. Toluene
(2 ml) containing the internal standard (C13:0) and
methanolic NaOH (2 ml) was added and the mixture
was incubated at 70°C (60 min) followed by 30 min at
50°C after addition of methanolic HCl (3 ml), prepared
by dissolving 10 ml acetyl chloride in 50 ml methanol.
Fatty acid methyl esters (FAME) were extracted with
hexane. Fatty acids in the TG fraction were methylated
as described by Chouinard et al. [30] whereas NEFAs
were methylated by an acid methylation step only. Fatty
acids in PL and CHE were methylated using a basic
followed by an acid methylation step.
Composition analyses of the FAs were conducted using
a gas chromatograph (HP 7890A, Agilent Technologies,Diegem, Belgium) equipped with a 75-m SP-2560™
capillary column (i.d., 0.18 mm, film thickness,
0.14 μm; Supelco Analytical, Bellefonte, PA) and a flame
ionization detector. The oven temperature program was
70°C before being raised to 175°C (50°C/min) for 13 min,
after which it was raised to 215°C (5°C/min) for 25 min.
The inlet temperature was 250°C and the detector
temperature 255°C. Various control materials were used:
BR2/BR3, (Larodan Fine Chemicals, Malmö, Sweden),
Supelco® 37 (Supelco Analytical, Bellefonte, PA), PUFA-3
(Matreya LLC, Pleasant Gap, PA) and GLC463 (NU-
CHEK-PREP Inc., Elysian, MN, USA). Fatty acids for
which no standards were commercially available were
identified by order of elution according to Precht et al.
[31] and Kramer et al. [32].
The FA analysis generated data on the concentrations
of lauric acid (12:0), myristic acid (14:0), pentadecaenoic
acid (15:0), palmitic acid (16:0), palmitoleic acid n-7
(16:1 n-7), palmitoleic acid n-9 (16:1 n-9), margaric acid
(17:0), stearic acid (18:0), oleic acid (18:1 n-9), vaccenic
acid n-11 (18:1 n-11), linoleic acid (18:2 n-6), arachidic
acid (20:0), gamma-linolenic acid (18:3 n-6), alfa-
linolenic acid (18:3 n-3), eicosenoic acid (20:1), eicosa-
dienoic acid (20:2), di-homo-gamma-linolenic acid (20:3
n-6), arachidonic acid (20:4 n-6), eicosapentaenoic acid
(20:5 n-3), docosatetraenoic acid (22:4 n-6), docosapen-
taenoic acid n-6 (22:5 n-6), docosapentaenoic acid n-3
(22:5 n-3), docosahexaenoic acid (22:6 n-3). For each FA
measurement, both the absolute (μmol/l) and the rela-
tive concentration (mol%) was determined. Fatty acids
were attributed to the PL, TG, CHE or NEFA fraction.
Statistical analyses
All statistical analyses were performed with PASW 18.0
(for Windows, Chicago, IL, USA) or R 2.13.1 [33]. Sev-
eral statistical hypothesis tests were carried out to study
the relation between patient characteristics and repro-
ductive outcome parameters, with the type of statistical
test depending on the nature of the outcome parameter.
Counted numbers were analyzed using Quasipoisson re-
gression (mean IVF attempt number, n. oocytes, n. 2PN,
n. embryos, n. top quality embryos), with an F-test as
described by Agresti [34]. Numeric variables were ana-
lyzed using linear regression (age, gonadotropin dose,
maximal estradiol values) and binary outcomes were
analyzed using logistic regression (live birth, percentage
of 2PN, percentage of embryos and top quality embryos,
calculated on the n. of oocytes and on the n. of 2PN).
The association between the number of embryos trans-
ferred and BMI was tested by means of a Kruskal –
Wallis test. Differences in the IVF/ICSI ratio were studied
by means of a Student’s t test. In these tests, BMI was
entered as a continuous variable. Univariate general
linear models, with post hoc Sheffé tests, were used to
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tions and between BMI groups. In these latter tests, BMI
was entered as a categorical variable. The same linear
model was used to study the FF FA composition between
PCOS and non-PCOS patients. Statistical significance was
set at P < 0.05. Fatty acid concentrations (absolute or rela-
tive) were log transformed in case their distribution was
not normal. Data are presented as means ± standard devi-
ation (SD).
Results
Patient characteristics
Patient characteristics are presented in Table 1. Our
data showed that increasing BMI was significantly asso-
ciated with a higher dosage of gonadotropins adminis-
tered (IU, P = 0.04). Also, increasing BMI was associated
with fewer 2PNs (P < 0.01) and lower 2PN percentages
(P = 0.03). There was no association between BMI and
age, mean IVF attempt number, IVF/ICSI ratio, the num-
ber of oocytes aspirated, the number of embryos, theTable 1 Patient information according to BMI class
18.5 ≤ BMI < 25.0 25.0 ≤
(n = 10) (n
Age (years) 31.5 ± 4.67 32.
Body Weight (kg) 61.6 ± 4.7 75.6
BMI (kg/m2) 21.5 ± 0.3 28.
Mean IVF attempt number 1.3 ± 0.7 2.0
ICSI/IVF 5/5
Gonadotropins administered (IU) 1793 ± 554 2100
Infertility cause (n)
Idiopathic 8
PCOS 1
Endometriosis 0
Tubal 1
No. oocytes 9.1 ± 3.6 7.2
No. 2PN 6.5 ± 2.2 4.5
No. 2PN/No. oocytes (%) 73.1 ± 12.0 67.3
No. embryos 2.3 ±1.2 1.5
No. embryos/No. oocytes (%) 30.2 ± 22.3 22.
No. embryos/No. 2PN (%) 39.8 ± 24.9 35.6
No. top quality embryos 2.0 ± 1.5 0.8
No. top quality embryos/No. oocytes (%) 26.9 ± 25.4 11.4
No. top quality embryos/No. 2PN (%) 34.5 ± 29.8 19.6
No. embryos transferred 1.1 ± 0.3 1.3
No. live births 3
Maximal E2 values (pg/ml) 1571 ± 445 139
The statistical method used and the associated P-value are presented in the last tw
Data are presented as mean ± standard deviation. BMI: body mass index, IVF: in vitr
pronuclei, E2: estradiol, NS: not significant (P > 0.05), NA: Not applicable.percentage of embryos, the number of top quality em-
bryos, the percentage of top quality embryos, the ratios ‘n.
embryos /n. 2PNs’ and ‘n. top quality embryos /n. 2PNs’,
the number of embryos transferred, the number of live
births and maximal estradiol values. As presented in
Table 1, PCOS patients were not excluded from the study.
This choice was made based on the observation that there
was no significant difference in FF FA concentrations in
the different lipid fractions between PCOS and non-PCOS
patients. Data from our previous study, from which the
cohort in this study is a subset, also showed that primary
infertility cause did not affect FF composition [17].
Total FA concentrations in the FF per lipid fraction
The distribution of FAs in the different lipid fractions in
FF from normal weight, overweight and obese women is
presented in Table 2. In obese women, NEFA concentra-
tions were elevated (P < 0.05) compared to normal
weight and overweight women. The concentration of
TG tended to be higher in overweight women, comparedBMI < 30.0 BMI ≥ 30.0 Statistical method P-value
= 10) (n = 10)
7 ± 4.3 35.0 ± 6.8 Linear regression NS
± 11.8 95.5 ± 11.4 NA
1 ± 1.5 34.2 ± 2.4 NA
± 1.3 2.2 ± 1.5 Quasipoisson regression NS
2/8 5/5 Student’s t test NS
± 1034 2645 ± 933 Linear regression 0.04
NA
7 7
1 2
2 0
0 1
± 2.9 6.7 ± 4.8 Quasipoisson regression NS
± 1.1 3.5 ± 2.1 Quasipoisson regression < 0.01
± 18.8 61.1 ± 24.9 Logistic regression 0.03
± 0.5 1.8 ± 0.6 Quasipoisson regression NS
8 ± 9.1 42.0 ± 32.1 Logistic regression NS
± 16.5 64.2 ± 28.2 Logistic regression NS
± 0.9 1.0 ± 1.1 Quasipoisson regression NS
± 15.2 19.4 ± 30.1 Logistic regression NS
± 24.8 30.2 ± 33.1 Logistic regression NS
± 0.5 1.5 ± 0.5 Quasipoisson regression NS
2 5 Logistic regression NS
9 ± 769 1505 ± 928 Linear regression NS
o columns.
o fertilization, PCOS: poly cystic ovarian syndrome, 2PN: presence of 2
Table 2 Fatty acids in follicular fluid of normal weight, overweight and obese women
Fat fraction 18.5 ≤ BMI < 25.0 (n = 10) 25.0 ≤ BMI < 30.0 (n = 10) BMI ≥ 30.0 (n = 10) P-value
Phospholipids (μmol/l) 1165.57 ± 180.55 1147.93 ± 247.63 1199.95 ± 296.46 NS
Cholesteryl esters (μmol/l) 920.04 ± 196.64 891.22 ± 117.35 1067.29 ± 269.40 NS
Triglycerides (μmol/l) 215.91 ± 57.89 355.39 ± 226.44 244.78 ± 74.65 0.1
NEFAs (μmol/l) 221.67 ± 23.00a 245.55 ± 35.98a 315.53 ± 82.68b < 0.05
Total concentration (μmol/l) 2598.56 ± 422.68 2769.88 ± 477.07 2931.80 ± 684.58 NS
Total fatty acid concentrations (μmol/l) in different lipid fractions in the follicular fluid of normal weight (18.5 ≤ BMI < 25), overweight (25.0 ≤ BMI < 30) and obese
(BMI ≥ 30.0) women.
Data are presented as means ± standard deviation. P-values of the univariate general linear model analyses are presented in the last column. abData with a
different superscript differ significantly (P < 0.05), NS: Not significant (P > 0.05), BMI: body mass index, NEFAs: non-esterified fatty acids.
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tions did not differ between BMI groups (Table 2). It is
noteworthy that the individually measured FA concen-
trations, in all the lipid fractions, had a relatively high
standard deviation. Forty-one up to 45% of the defined
FAs in the FF could be attributed to the PL fraction,
32-36% to the CHE fraction, 8-13% to the TG fraction
and 9-11% to the NEFA fraction and this distribution
did not differ between BMI groups. Total concentra-
tions, presented in Table 2, also included measures of
unknown FAs (accounting for approximately 5% of the
total FA concentration).
BMI dependent distribution of FAs in different lipid
classes
Total fat extract
The most abundant FAs in the FF were 16:0, 18:0, 18:1
n-9, 18:2 n-6 and 20:4 n-6. No significant differences
could be found for neither absolute nor relative concen-
trations of the individual FAs between BMI groups.
Individual FA concentrations in the different lipid frac-
tions are presented in Table 3.
Phospholipid fraction
The 4 most abundant FAs in the PL fraction of FF
were 16:0, 18:0, 18:2 n-6 and 20:4 n-6 (Table 3), none
of which were affected by BMI. On the contrary, the
relative percentage of 18:1 n-9 was higher in normal
weight women compared to overweight and obese women
(P < 0.01) and the percentage of 20:3 n-6 was higher in
overweight and obese women, compared to normal weight
women (P = 0.04). There were no other BMI-related
differences in FF FAs.
Cholesteryl-ester fraction
The most abundant FAs in this fraction were 16:0, 18:1 n-9,
18:2 n-6 and 20:4 n-6 (Table 3). Both the absolute and
the relative concentration of 20:3 n-6 were significantly
different between obese women and normal weight women
(P = 0.04 and P = 0.02, respectively). There were no other
BMI-related differences in the remaining FF FAs.Triglyceride fraction
16:0, 18:0, 18:1 n-9 and 18:2 n-6 were major FAs in
the TG fraction (Table 3). A significant elevation in
the absolute concentration of 18:2 n-6 (P = 0.04) and
22:6 n-3 (P = 0.03) was found for overweight women,
compared to normal weight women. There were no
significant differences in the relative concentrations of
the FAs.
Non-esterified fatty acid fraction
The most abundant FA is het NEFA fraction were 16:0,
18:0, 18:1 n-9 and 18:2 n-6 (Table 3). Absolute concen-
trations of 14:0, 15:0, 16:1 n-7, 16:1 n-9, 17:0, 18:0, 18:1
n-9, 18:1 n-11, 18:2 n-6, 20:2, 20:3 n-6, 20:5 n-3, 22:5 n-6,
22:5 n-3 and 22:6 n-3 were higher in obese compared to
normal weight women (P < 0.05). Additionally, absolute
concentrations of 16:0, 18:3 n-6, 20:4 n-6 and 22:4 n-6
were higher in obese compared to normal weight and
overweight women (P < 0.05). Furthermore, obese women
had higher concentrations of 20:1 compared to overweight
women (P < 0.05). Relative concentrations only showed a
significant elevation in 20:4 n-6 for overweight and obese
women, compared to normal weight women (P < 0.05)
and an elevation in 20:3 n-6 for obese women, compared
to normal weight women (P < 0.01).
Discussion
The aim of this study was to provide insight in the FA
profile, specified per lipid fraction, in the FF of the pre-
ovulatory follicle from normal weight, overweight and
obese women, undergoing ART. To our knowledge, this
is the first time that FAs in human FF lipid fractions are
described in such detail. Our results showed that ap-
proximately 42% of the total FA concentration was es-
terified in the PL fraction and 34% in the CHE fraction,
whereas only 10% were present in both the TG and
NEFA fraction. Interestingly, only TG (trend) and NEFA
concentrations were affected by BMI. Even though FA
concentrations in the NEFA fraction were well below
those of the other fractions, they showed the most BMI-
related variability.
Table 3 Fatty acid concentrations in different lipid fractions
Phopholipid Absolute concentrations (μM) Relative concentrations (mol%)
Normal weight Overweight Obese Normal weight Overweight Obese
12:0 0,0 ± 0,0 0,2 ± 0,3 0,2 ± 0,6 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
14:0 4,1 ± 1,1 4,6 ± 1,8 4,1 ± 1,1 0,3 ± 0,1 0,4 ± 0,1 0,3 ± 0,1
15:0 2,7 ± 0,6 2,7 ± 0,7 2,4 ± 0,4 0,2 ± 0,0 0,2 ± 0,0 0,2 ± 0,0
16:0 359,4 ± 53,1 360,9 ± 92,0 383,5 ± 129,0 30,9 ± 1,1 31,3 ± 1,7 31,5 ± 2,6
16:1 n-7 1,7 ± 0,3 1,7 ± 0,4 1,6 ± 0,2 0,1 ± 0,0 0,2 ± 0,0 0,1 ± 0,0
16:1 n-9 5,8 ± 1,8 6,2 ± 2,8 5,5 ± 1,8 0,5 ± 0,1 0,5 ± 0,1 0,5 ± 0,1
17:0 4,3 ± 0,8 4,3 ± 0,8 4,2 ± 0,8 0,4 ± 0,0 0,4 ± 0,0 0,4 ± 0,1
18:0 160,0 ± 26,6 160,6 ± 24,2 164,2 ± 25,0 13,7 ± 1,0 14,2 ± 1,5 14,0 ± 2,1
18:1 n-9 104,2 ± 16,9 91,4 ± 26,4 95,1 ± 25,6 9,0 ± 0,7a 7,9 ± 0,8b 7,9 ± 0,7b
18:1 n-11 17,8 ± 2,9 16,9 ± 4,4 15,8 ± 4,0 1,5 ± 0,2 1,5 ± 0,2 1,3 ± 0,2
18:2 n-6 218,1 ± 39,7 191,1 ± 36,7 190,1 ± 26,1 18,7 ± 1,7 16,8 ± 2,2 16,3 ± 2,7
20:0 0,9 ± 0,1 0,8 ± 0,1 0,8 ± 0,1 0,1 ± 0,0 0,1 ± 0,0 0,1 ± 0,0
18:3 n-6 0,3 ± 0,1 0,4 ± 0,2 0,4 ± 0,1 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
18:3 n-3 2,7 ± 0,7 2,4 ± 0,8 2,1 ± 0,6 0,2 ± 0,1 0,2 ± 0,1 0,2 ± 0,1
20:1 2,3 ± 0,3 2,3 ± 0,5 2,2 ± 0,4 0,2 ± 0,0 0,2 ± 0,0 0,2 ± 0,0
20:2 4,9 ± 1,3 5,3 ± 1,2 5,0 ± 0,9 0,4 ± 0,1 0,5 ± 0,1 0,4 ± 0,1
20:3 n-6 40,1 ± 14,2 45,8 ± 8,5 48,7 ± 12,5 3,4 ± 0,7a 4,0 ± 0,6b 4,1 ± 0,6b
20:4 n-6 126,2 ± 19,4 132,2 ± 34,4 154,2 ± 63,4 10,9 ± 0,7 11,5 ± 1,6 12,5 ± 2,1
20:5 n-3 9,2 ± 3,0 12,3 ± 7,2 12,7 ± 5,7 0,8 ± 0,2 1,0 ± 0,5 1,0 ± 0,4
22:4 n-6 4,8 ± 0,7 5,1 ± 1,3 5,3 ± 2,0 0,4 ± 0,0 0,4 ± 0,1 0,4 ± 0,1
22:5 n-6 3,6 ± 1,0 3,8 ± 1,4 3,5 ± 1,4 0,3 ± 0,1 0,3 ± 0,1 0,3 ± 0,1
22:5 n-3 12,2 ± 1,6 12,6 ± 3,4 11,5 ± 3,4 1,1 ± 0,1 1,1 ± 0,1 1,0 ± 0,2
22:6 n-3 48,6 ± 11,0 54,7 ± 18,1 57,9 ± 19,7 4,2 ± 0,7 4,7 ± 0,9 4,8 ± 0,9
unknown 31,8 ± 9,6 29,7 ± 8,5 29,1 ± 7,7 - - -
total 1165,6 ± 180,6 1147,9 ± 247,6 1200,0 ± 296,5 - - -
Cholesteryl ester Absolute concentrations (μM) Relative concentrations (mol%)
Normal weight Overweight Obese Normal weight Overweight Obese
12:0 19,6 ± 14,7 23,1 ± 15,0 22,7 ± 14,4 2,1 ± 1,6 2,6 ± 2,1 1,8 ± 1,4
14:0 15,9 ± 7,9 17,7 ± 8,5 18,1 ± 8,0 1,7 ± 0,8 2,0 ± 1,7 0,9 ± 0,7
15:0 2,2 ± 0,7 2,0 ± 0,7 2,2 ± 0,6 0,2 ± 0,1 0,2 ± 0,2 0,0 ± 0,1
16:0 104,8 ± 21,8 103,9 ± 20,7 131,3 ± 45,3 11,4 ± 0,3 11,6 ± 12,1 1,1 ± 1,1
16:1 n-7 4,1 ± 1,1 4,0 ± 0,9 4,7 ± 1,8 0,4 ± 0,0 0,4 ± 0,4 0,1 ± 0,1
16:1 n-9 19,2 ± 7,9 21,1 ± 10,3 25,0 ± 16,5 2,0 ± 0,5 2,3 ± 2,2 1,0 ± 1,0
17:0 1,2 ± 0,2 1,3 ± 0,2 1,4 ± 0,5 0,1 ± 0,0 0,2 ± 0,1 0,0 ± 0,0
18:0 7,7 ± 1,5 8,1 ± 0,7 12,9 ± 13,7 0,8 ± 0,1 0,9 ± 1,1 0,1 ± 0,9
18:1 n-9 163,1 ± 34,4 147,6 ± 24,6 188,1 ± 66,4 17,8 ± 0,9 16,5 ± 17,3 1,4 ± 1,9
18:1 n-11 11,2 ± 2,0 10,3 ± 2,6 12,2 ± 4,2 1,2 ± 0,1 1,1 ± 1,1 0,2 ± 0,1
18:2 n-6 415,0 ± 102,5 386,7 ± 52,4 437,6 ± 65,9 45,0 ± 3,6 43,5 ± 42,0 4,0 ± 5,7
20:0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
18:3 n-6 3,7 ± 2,1 3,9 ± 1,3 5,1 ± 2,2 0,4 ± 0,1 0,4 ± 0,5 0,1 ± 0,2
18:3 n-3 4,2 ± 1,3 4,3 ± 1,2 5,5 ± 4,4 0,5 ± 0,1 0,5 ± 0,5 0,1 ± 0,3
20:1 0,0 ± 0,0 0,0 ± 0,0 0,2 ± 0,7 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
20:2 0,0 ± 0,0 0,0 ± 0,0 0,1 ± 0,4 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
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Table 3 Fatty acid concentrations in different lipid fractions (Continued)
20:3 n-6 7,3 ± 2,8a 8,5 ± 1,6ab 10,1 ± 2,3b 0,8 ± 0,2a 1,0 ± 1,0ab 0,2 ± 0,1b
20:4 n-6 65,8 ± 14,4 71,6 ± 18,6 94,7 ± 39,7 7,2 ± 0,8 8,0 ± 8,8 1,4 ± 2,1
20:5 n-3 6,5 ± 2,3 8,4 ± 4,9 10,4 ± 5,4 0,7 ± 0,2 0,9 ± 1,0 0,5 ± 0,4
22:4 n-6 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
22:5 n-6 0,1 ± 0,2 0,1 ± 0,2 0,2 ± 0,3 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
22:5 n-3 1,3 ± 0,3 1,2 ± 0,1 1,0 ± 0,3 0,1 ± 0,1 0,1 ± 0,1 0,0 ± 0,0
22:6 n-3 5,6 ± 1,6 6,6 ± 2,1 8,0 ± 2,8 0,6 ± 0,1 0,7 ± 0,8 0,2 ± 0,2
unknown 61,6 ± 8,0 60,7 ± 5,5 75,9 ± 37,6 - - -
total 920,0 ± 196,6 891,2 ± 117,4 1067,3 ± 269,4 - - -
Triglyceride Absolute concentrations (μM) Relative concentrations (mol%)
Normal weight Overweight Obese Normal weight Overweight Obese
12:0 2,0 ± 0,6 3,3 ± 3,1 2,4 ± 0,5 1,0 ± 0,3 0,9 ± 0,3 1,0 ± 0,2
14:0 5,6 ± 2,1 9,8 ± 8,1 6,8 ± 2,8 2,6 ± 0,7 2,7 ± 0,6 2,8 ± 0,6
15:0 1,1 ± 0,2 1,4 ± 0,6 1,1 ± 0,3 0,5 ± 0,1 0,4 ± 0,1 0,5 ± 0,1
16:0 51,4 ± 15,4 90,7 ± 70,1 60,8 ± 21,9 23,6 ± 1,2 24,4 ± 2,5 24,5 ± 2,4
16:1 n-7 2,2 ± 0,6 3,2 ± 1,7 2,3 ± 0,4 1,0 ± 0,1 1,0 ± 0,2 1,0 ± 0,3
16:1 n-9 6,5 ± 3,3 11,8 ± 11,6 7,1 ± 2,9 2,9 ± 0,8 3,1 ± 0,8 2,9 ± 0,5
17:0 0,8 ± 0,2 1,2 ± 0,7 0,9 ± 0,3 0,4 ± 0,0 0,4 ± 0,1 0,4 ± 0,1
18:0 11,2 ± 4,3 19,5 ± 14,7 15,2 ± 10,5 5,2 ± 1,1 5,5 ± 2,0 5,9 ± 2,1
18:1 n-9 76,7 ± 22,9 120,9 ± 74,0 83,4 ± 29,3 35,3 ± 1,9 34,1 ± 2,3 33,9 ± 1,9
18:1 n-11 4,2 ± 1,5 7,4 ± 5,0 4,7 ± 1,8 1,9 ± 0,2 2,1 ± 0,3 1,9 ± 0,2
18:2 n-6 27,2 ± 7,7a 46,8 ± 26,0b 30,5 ± 8,0ab 12,6 ± 1,4 13,6 ± 1,9 12,8 ± 2,5
20:0 0,3 ± 0,0 0,4 ± 0,2 0,3 ± 0,1 0,1 ± 0,0 0,1 ± 0,0 0,1 ± 0,0
18:3 n-6 0,4 ± 0,2 0,7 ± 0,5 0,5 ± 0,3 0,2 ± 0,0 0,2 ± 0,1 0,2 ± 0,1
18:3 n-3 2,4 ± 0,9 4,4 ± 3,3 3,0 ± 2,0 1,2 ± 0,3 1,2 ± 0,5 1,2 ± 0,6
20:1 0,7 ± 0,2 1,4 ± 1,0 0,8 ± 0,5 0,3 ± 0,1 0,4 ± 0,1 0,3 ± 0,1
20:2 0,7 ± 0,2 1,0 ± 0,5 0,7 ± 0,2 0,4 ± 0,1 0,3 ± 0,1 0,3 ± 0,1
20:3 n-6 0,4 ± 0,1 0,9 ± 0,8 0,5 ± 0,1 0,2 ± 0,0 0,2 ± 0,1 0,2 ± 0,1
20:4 n-6 2,1 ± 0,7 4,2 ± 3,5 3,5 ± 1,7 1,0 ± 0,2 1,3 ± 0,6 1,5 ± 0,7
20:5 n-3 0,6 ± 0,2 1,2 ± 0,9 0,8 ± 0,4 0,3 ± 0,1 0,3 ± 0,1 0,3 ± 0,1
22:4 n-6 0,5 ± 0,2 0,6 ± 0,5 0,4 ± 0,2 0,2 ± 0,1 0,2 ± 0,1 0,2 ± 0,1
22:5 n-6 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,1 0,0 ± 0,0 0,0 ± 0,0 0,0 ± 0,0
22:5 n-3 0,4 ± 0,1 0,8 ± 0,9 0,4 ± 0,1 0,2 ± 0,0 0,2 ± 0,1 0,2 ± 0,0
22:6 n-3 0,5 ± 0,2a 1,9 ± 2,9b 1,0 ± 0,4ab 0,2 ± 0,1 0,4 ± 0,3 0,4 ± 0,2
unknown 17,9 ± 3,6 21,8 ± 7,9 17,7 ± 4,1 - - -
total 215,9 ± 57,9 355,4 ± 226,4 244,8 ± 74,7 - - -
NEFA Absolute concentrations (μM) Relative concentrations (mol%)
Normal weight Overweight Obese Normal weight Overweight Obese
12:0 2,0 ± 0,6 2,6 ± 1,4 2,7 ± 0,9 0,9 ± 0,3 1,0 ± 0,6 0,9 ± 0,3
14:0 4,6 ± 0,6a 5,1 ± 1,0ab 6,4 ± 1,7b 2,1 ± 0,2 2,1 ± 0,2 2,0 ± 0,2
15:0 0,5 ± 0,1a 0,6 ± 0,1ab 0,7 ± 0,2b 0,2 ± 0,0 0,2 ± 0,0 0,2 ± 0,1
16:0 51,4 ± 6,4a 55,7 ± 7,2a 70,3 ± 17,1b 23,2 ± 1,6 22,8 ± 1,6 22,5 ± 2,1
16:1 n-7 0,8 ± 0,1a 1,0 ± 0,2ab 1,4 ± 0,5b 0,4 ± 0,0 0,4 ± 0,0 0,4 ± 0,1
16:1 n-9 6,3 ± 1,5a 7,7 ± 1,7ab 10,2 ± 3,8b 2,8 ± 0,6 3,1 ± 0,4 3,2 ± 0,6
17:0 0,6 ± 0,1a 0,7 ± 0,1ab 0,8 ± 0,3b 0,3 ± 0,0 0,3 ± 0,0 0,3 ± 0,1
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Table 3 Fatty acid concentrations in different lipid fractions (Continued)
18:0 19,7 ± 3,6a 20,3 ± 2,9ab 24,8 ± 5,6b 8,9 ± 1,4 8,3 ± 0,9 8,1 ± 1,5
18:1 n-9 68,1 ± 8,3a 76,9 ± 13,5ab 102,5 ± 34,1b 30,7 ± 1,8 31,3 ± 1,8 32,1 ± 3,3
18:1 n-11 5,8 ± 0,9a 6,5 ± 1,6ab 9,0 ± 3,0b 2,6 ± 0,3 2,6 ± 0,4 2,8 ± 0,4
18:2 n-6 37,1 ± 5,3a 40,0 ± 7,8ab 49,7 ± 12,9b 16,8 ± 2,1 16,3 ± 2,1 15,9 ± 1,7
20:0 0,4 ± 0,0 0,4 ± 0,0 0,5 ± 0,1 0,2 ± 0,0 0,2 ± 0,0 0,1 ± 0,0
18:3 n-6 0,4 ± 0,1a 0,5 ± 0,1a 0,7 ± 0,2b 0,2 ± 0,0 0,2 ± 0,0 0,2 ± 0,1
18:3 n-3 1,2 ± 0,3 1,5 ± 0,5 2,1 ± 2,1 0,5 ± 0,1 0,6 ± 0,1 0,6 ± 0,4
20:1 1,7 ± 0,3ab 1,7 ± 0,4a 2,3 ± 0,7b 0,8 ± 0,1 0,7 ± 0,1 0,7 ± 0,1
20:2 1,5 ± 0,4a 1,6 ± 0,5ab 2,1 ± 0,7b 0,7 ± 0,2 0,6 ± 0,1 0,7 ± 0,2
20:3 n-6 0,5 ± 0,1a 0,6 ± 0,1ab 0,9 ± 0,3b 0,2 ± 0,0a 0,3 ± 0,0ab 0,3 ± 0,1b
20:4 n-6 1,2 ± 0,3a 1,8 ± 0,4a 2,3 ± 0,7b 0,6 ± 0,1a 0,7 ± 0,1b 0,7 ± 0,1b
20:5 n-3 0,2 ± 0,1a 0,3 ± 0,1ab 0,3 ± 0,1b 0,1 ± 0,0 0,1 ± 0,0 0,1 ± 0,0
22:4 n-6 2,1 ± 0,6a 2,0 ± 0,6a 3,5 ± 1,2b 0,9 ± 0,2 0,8 ± 0,2 1,1 ± 0,4
22:5 n-6 0,5 ± 0,1a 0,5 ± 0,1ab 0,7 ± 0,3b 0,2 ± 0,1 0,2 ± 0,0 0,2 ± 0,1
22:5 n-3 0,6 ± 0,2a 0,8 ± 0,3ab 1,2 ± 0,4b 0,3 ± 0,1 0,3 ± 0,1 0,4 ± 0,1
22:6 n-3 1,4 ± 0,5a 1,9 ± 0,8ab 2,7 ± 1,1b 0,6 ± 0,2 0,8 ± 0,3 0,9 ± 0,2
unknown 13,1 ± 3,3 14,9 ± 3,8 17,8 ± 6,0 - - -
total 221,7 ± 23,0a 245,6 ± 36,0a 315,5 ± 82,7b - - -
Data are presented as means ± standard deviation. abData with a different superscript within absolute or relative concentrations, differ significantly
(P < 0.05). BMI: Body Mass Index, NEFA: Non-esterified fatty acid.
Absolute (μM) and relative (mol%) fatty acid concentrations in the phospholipid, cholesteryl ester, triglyceride and non-esterified fat fraction in the follicular
fluid of normal weight (18.5 ≤ BMI < 25.0), overweight (25.0 ≤ BMI < 30.0) and obese (BMI ≥ 30.0) women undergoing assisted reproductive services.
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obese women, which is confirmed by earlier work [18].
However, it is in contrast with our previous findings [17]
and with the data of Robker et al. [35], who could not
show a BMI-related difference in FF total NEFA concen-
trations. The difference between these data and those of
our previous study, could partially be explained by a large
variation in NEFA concentrations, the use of a dif-
ferent (colorimetric versus gas chromatographic) analysis
methods and the inequality of the number of patients
within each BMI group in our previous study [17]. Re-
markably, our data also showed that even though absolute
NEFA concentrations presented with a great BMI-related
variability, relative concentrations only showed minor dif-
ferences, suggesting that increasing BMI did not cause a
shift in the relative abundance of the different FAs. Inter-
estingly, Jungheim et al. [19] found that women with ele-
vated levels of FF NEFAs displayed poorer cumulus-
oocyte complex (COC) morphology. They differentiated
between FF palmitic, stearic, oleic and linoleic acid in the
NEFA fraction, but no correlations with BMI were found.
Our data showed that 87% (20/23) of all FAs in the NEFA
fraction, including palmitic, stearic, oleic and linoleic acid,
correlated with BMI, which suggests that BMI causes
changes in the FF NEFA concentrations that could directly
affect COC function and quality. This is substantiated by
the fact that we previously showed that bovine oocyteexposure, during the final stage of maturation, to elevated
NEFA concentrations (oleic, palmitic and/or stearic acid)
was detrimental for the oocyte’s developmental capacity
[15]. It also altered gene expression patterns and energy/
amino acid metabolism in blastocysts from oocytes ex-
posed during the last 24 h of maturation [20]. Aardema
et al. [36] showed that oocytes actively take up and
metabolize NEFAs out of their environment (mitochon-
drial β-oxidation for the purpose of ATP production) and
that this may influence lipid storage in lipid droplets
within the oocyte, depending on the type and amount of
FA offered. More specifically, oocytes exposed to palmitic
and stearic acid presented with less intracellular fat stor-
age and a hampered oocyte developmental competence.
This effect could be counteracted by the addition of oleic
acid to the treatment [36]. Such a protective effect of the
mono-unsaturated FA oleic acid has also been proposed
by Cnop et al. [37] in pancreatic islet cells, where oleic
acid was described to reduce palmitate induced lipotoxi-
city, possibly by promoting triglyceride formation (cyto-
protective mechanism). Our recent research investigated
the mechanisms behind this lipotoxicity and showed that
the degree of mitochondrial FA beta-oxidation has a
strong impact on the development of NEFA exposed
bovine oocytes and on the quality of the resulting embryos
[21]. Besides the oocyte, the somatic cells of the follicle
might also be influenced by the composition of FAs in the
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in vitro bovine granulosa and theca cell proliferation and
to alter steroid production by inducing apoptosis [38,39].
Arachidonic acid, on the other hand, protects human
granulosa cells from palmitic and stearic acid-induced
apoptosis [40]. The effects of poly-unsaturated FAs are less
uniform as for example linoleic acid (18:2 n-6) hampers
and linolenic acid (18:3 n-3) stimulates bovine nuclear oo-
cyte maturation [6,8,41,42]. Interestingly, linoleic acid was
present in the FF as one of the most predominant FAs.
Marei et al. [41] showed that exposure of bovine cumulus-
oocyte complexes to elevated linoleic acid concentrations
during final maturation impaired oocyte maturation and
decreased oocyte developmental competence. This may
imply that elevated levels of linoleic acid could have harm-
ful effects on fertility outcome in women. Under normal
circumstances, linoleic acid concentrations are decreased
in the FF of large follicles, compared to smaller follicles
[43]. This suggest that linoleic acid can play an important
role in the regulation of oocyte maturation, with decreas-
ing levels allowing progression of oocyte maturation.
In all the previously discussed in vitro studies, FAs are
added to the medium as non-esterified FAs. It remains,
however, unclear if the same FAs, but esterified to a dif-
ferent fat fraction might elicit a differential effect. For
example, a FA derived from the hydrolysis of TGs, con-
tained in for example very low-density lipoproteins, by
lipoprotein lipase [44], could potentially exert a different
effect at the level of the cell, compared to the same FA
in the NEFA fraction.
Besides the total NEFA concentrations, also total TG
concentrations tended to be increased in overweight
women. Interestingly, when mouse oocytes were ma-
tured in medium supplemented with NEFA/TG rich hu-
man FF, a dramatic decrease in oocyte maturation to
metaphase 2, an increased oocyte lipid content and an
upregulation of genes related to endoplasmic reticulum
stress could be observed [18]. This suggests a detrimen-
tal effect of elevated TG and/or NEFA concentrations
on oocyte quality. It is however not clear whether this
is caused by elevated TG or NEFA concentrations or
both or to what particular compound in the FF this ef-
fect can be attributed. Remarkably, 18:2 n-6 and 22:6
n-3 in the TG fraction were elevated in the FF of over-
weight, but not obese women, compared to normal
weight women. A potential reason for this could be that
in a first coping mechanism excess FAs, present in over-
weight individuals, are stored in lipid droplets [45].
However, in obese women, much of the circulating FAs
originate from abdominal fat adipocytes [45], which are
rich in saturated and mono-unsaturated FAs [46,47].
High levels of the saturated palmitic and stearic acid
have been shown to reduce lipid storage in maturing bo-
vine oocytes [36]. This is in agreement with our data,showing that obese women presented with elevated
levels of many FA in the NEFA fraction, rather than in
the TG fraction for potential storage in lipid droplets.
We have previously shown that a strong correlation
exists between serum and FF metabolites, indicating that
the serum composition influences the FF composition
[17]. However, these changes were not BMI-related, in-
dicating that factors, other than serum composition have
a large impact on FF composition. Furthermore, the po-
tential impact of differential FAs in the FF on oocyte de-
velopmental competence depends on the actual presence
and the ratios of FAs within the FF. Therefore, the pri-
mary focus of our study was to describe FF FAs, rather
than to investigate their relation to the serum compos-
ition. We furthermore did not have any knowledge on
diet or fasting before sampling, even though it has been
well described that diet can change the FF FA compos-
ition and can thereby affect oocyte developmental com-
petence and subsequent embryo quality [48].
Another remark is that obese women required a higher
dosage of gonadotropins to reach the same stimulatory ef-
fect on follicular development, compared to normal
weight women. However, it has also been described that
gonadotropin releasing hormone analogues can alter
serum lipoprotein levels and can increase insulin resist-
ance [49], potentially deteriorating the insulin resistant
state in many obese women. Because of ethical restraints
in proposing suboptimal gonadotropin concentration ad-
ministration, we were unable to account for this potential
confounding factor in our study.
Conclusions
This descriptive study reports on the FA concentrations
in the PL, CHE, TG and NEFA fraction in the FF of nor-
mal weight, overweight and obese women, undergoing
ART. Our study highlights that most FAs in the FF be-
long to the PL and CHE fat fraction, but that NEFAs
presented with the greatest BMI-related variability, with
most individual FA concentrations increased in obese
women. These differences may affect oocyte quality and
subsequent embryo development, possibly by acting dir-
ectly on oocyte metabolism.
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